KCM
Knoll Capital Management’s Enlivex Therapeutics ENLV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-206,054
| Closed | -$214K | – | 18 |
|
|
2016
Q4 | $214K | Sell |
206,054
-44,916
| -18% | -$46.6K | 0.38% | 16 |
|
|
2016
Q3 | $424K | Hold |
250,970
| – | – | 0.74% | 16 |
|
|
2016
Q2 | $402K | Hold |
250,970
| – | – | 0.13% | 16 |
|
|
2016
Q1 | $625K | Sell |
250,970
-87,140
| -26% | -$217K | 0.25% | 15 |
|
|
2015
Q4 | $1.31M | Hold |
338,110
| – | – | 0.49% | 11 |
|
|
2015
Q3 | $1.72M | Hold |
338,110
| – | – | 0.73% | 9 |
|
|
2015
Q2 | $2.33M | Hold |
338,110
| – | – | 0.75% | 9 |
|
|
2015
Q1 | $2.03M | Hold |
338,110
| – | – | 0.59% | 8 |
|
|
2014
Q4 | $2.16M | Hold |
338,110
| – | – | 0.85% | 7 |
|
|
2014
Q3 | $2.46M | Buy |
+338,110
| New | +$2.46M | 0.96% | 5 |
|